Back to the Future: Introduction and Conclusions

Slides:



Advertisements
Similar presentations
Volume 42, Issue 1, Pages 7-11 (July 2002)
Advertisements

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Medical Management for BPH: The Role of Combination Therapy
Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men: The Osteoporotic Fractures in Men Study  Kathleen F. Holton,
Pascal Rischmann  European Urology Supplements 
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Volume 72, Issue 1, Pages (January 2017)
Volume 68, Issue 3, Pages (September 2015)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management  Michael O’Leary  European Urology Supplements 
Management of Acute and Chronic Retention in Men
Volume 54, Issue 6, Pages (December 2008)
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)  Raymond C. Rosen, Francois Giuliano, Culley.
Volume 52, Issue 3, Pages (September 2007)
Volume 60, Issue 1, Pages (July 2011)
Volume 60, Issue 4, Pages (October 2011)
Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening?  Bob Djavan  European.
Counselling the Prostate Cancer Patient
Laurent Boccon-Gibod  European Urology Supplements 
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 44, Issue 5, Pages (November 2003)
An Update of Current Practice in Hypospadias Surgery
Richard C. Harkaway  European Urology Supplements 
Volume 50, Issue 5, Pages (November 2006)
Volume 46, Issue 5, Pages (November 2004)
Tim Schneider  European Urology Supplements 
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Transurethral Resection of the Prostate
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
The Importance of Testosterone Control in Prostate Cancer
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
Neal Shore  European Urology Supplements 
Volume 54, Issue 6, Pages (December 2008)
When to Treat the Prostate, the Bladder, or Both?
Sergio Bracarda  European Urology Supplements 
Volume 53, Issue 6, Pages (June 2008)
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
Christian Stief  European Urology Supplements 
New Trends in Managing the Prostate Cancer Patient
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Martin Michel, Jean de la Rosette  European Urology Supplements 
Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer  P. Mongiat-Artus, P. Teillac 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
Improving Flexibility and Quality of Life for Your Patients: A Must?
The Burden of Stress Urinary Incontinence
Profile of Silodosin European Urology Supplements
New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men
Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
The Benefits of Dual Inhibition of 5α Reductase
C.G Roehrborn, T McNicholas  European Urology Supplements 
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Counselling of the Prostate Cancer Patient as a Whole Person
Joaquim Bellmunt  European Urology Supplements 
Classification of Mixed Incontinence
The Impact of Premature Ejaculation on Partners and Relationships
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Integrating Patient Risk Profiles in the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) in Clinical Practice 
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Epidemiology and Demographics of Prostatitis
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer  Noel W. Clarke  European Urology Supplements 
Jan Roigas  European Urology Supplements 
Michael Marberger  European Urology Supplements 
Vassilios Tzortzis, Stavros Gravas, Jean J.M.C.H. de la Rosette 
Presentation transcript:

Back to the Future: Introduction and Conclusions Philip Van Kerrebroeck  European Urology Supplements  Volume 7, Issue 11, Pages 675-679 (November 2008) DOI: 10.1016/j.eursup.2008.07.008 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 Main characteristics of 408 urologists participating in a web-based survey on the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia by means of clinical cases: (a) Geographical origin of the respondents; (b) gender of the respondents; (c) number of years that respondents have been in practice; (d) main practice setting of respondents; (e) amount of time spent by respondents on patient care. For the clinical cases, only the answers of the 382 respondents who spent more than 25% of their time on patient care were analysed. European Urology Supplements 2008 7, 675-679DOI: (10.1016/j.eursup.2008.07.008) Copyright © 2008 European Association of Urology Terms and Conditions